Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Growth Metrics

National Healthcare Properties (NHPBP) Preferred Shares Repurchased (2025)

National Healthcare Properties has reported Preferred Shares Repurchased over the past 1 years, most recently at $897000.0 for Q4 2025.

For Q4 2025, Preferred Shares Repurchased changed N/A year-over-year to $897000.0; the TTM value through Dec 2025 reached $3.7 million, changed N/A, while the annual FY2025 figure was $5.4 million, N/A changed from the prior year.
Preferred Shares Repurchased for Q4 2025 was $897000.0 at National Healthcare Properties, down from $2.8 million in the prior quarter.
Over five years, Preferred Shares Repurchased peaked at $2.8 million in Q3 2025 and troughed at $897000.0 in Q4 2025.